Vicki Seyfert-Margolis, Ph.D. Founder of MyOwnMed
I have always been interested in how to disrupt the system of basic and clinical medical research in order to achieve better outcomes for people afflicted with disease. For me, it started with building systems that incorporated biomarker discovery and patient selection strategies to better predict which patients would truly benefit from which therapies, keeping in mind that most patients and practitioners are not in treatment at the top academic medical centers. Unfortunately, most drugs underperform once they are broadly launched into the market.